Increased expression level of the splicing variant of SIP1 in motor neuron diseases

被引:8
作者
Aerbajinai, W
Ishihara, T
Arahata, K
Tsukahara, T
机构
[1] NCNP, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo 1878502, Japan
[2] Natl Higashi Saitama Hosp, Hasuda, Saitama 3490196, Japan
[3] Japan Sci & Technol Corp, CREST, Tokyo, Japan
关键词
SMN interacting protein 1 (SIP1); splicing variant (SIP1-beta); spinal muscular atrophy (SMA); amyotrophic lateral sclerosis (ALS);
D O I
10.1016/S1357-2725(01)00150-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survival motor neuron (SMN) interacting protein 1 (SIP1) interacts with SMN protein and plays a crucial role in the biogenesis of spliceosomes. We have identified three novel splicing variants of the SIP1 (SIP1-beta, -gamma and -delta), in addition to the full-length SIP1-alpha. SIP1-alpha as found to be ubiquitously expressed at high levels in the various normal tissues examined. In contrast, SIP1-beta and -gamma were expressed at very low levels in these tissues. In muscle specimens from patients with spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), the expression of SIP1-alpha was dramatically decreased compared to that observed in the normal tissues. In addition, the expression of SIP1-beta was significantly increased in tissues derived from patients with either disease. These findings suggest that an aberrant alternative splicing event in SIP1 occurs tissues derived from patients with the motor neuron diseases, and contributes to the pathological process of SMA and ALS. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:699 / 707
页数:9
相关论文
共 23 条
[1]   Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis [J].
Aoki, M ;
Lin, CLG ;
Rothstein, JD ;
Geller, BA ;
Hosler, BA ;
Munsat, TL ;
Horvitz, HR ;
Brown, RH .
ANNALS OF NEUROLOGY, 1998, 43 (05) :645-653
[2]   Aberrant RNA splicing in sporadic amyotrophic lateral sclerosis [J].
Bai, G ;
Lipton, SA .
NEURON, 1998, 20 (03) :363-366
[3]  
COLLIER DA, 1998, MOL PSYCHIATR, V3, P298
[4]   The regulation of splice-site selection, and its role in human disease [J].
Cooper, TA ;
Mattox, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) :259-266
[5]   The splice of life: Alternative splicing and neurological disease [J].
Dredge, BK ;
Polydorides, AD ;
Darnell, RB .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (01) :43-50
[6]  
Dubowitz V, 1995, MUSCLE DISORDERS CHI, P540
[7]   The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis [J].
Fischer, U ;
Liu, Q ;
Dreyfuss, G .
CELL, 1997, 90 (06) :1023-1029
[8]   Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy [J].
Iwahashi, H ;
Eguchi, Y ;
Yasuhara, N ;
Hanafusa, T ;
Matsuzawa, Y ;
Tsujimoto, Y .
NATURE, 1997, 390 (6658) :413-417
[9]   Alternative splicing and programmed cell death [J].
Jiang, ZH ;
Wu, JY .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 220 (02) :64-72
[10]   Correlation between severity and SMN protein level in spinal muscular atrophy [J].
Lefebvre, S ;
Burlet, P ;
Liu, Q ;
Bertrandy, S ;
Clermont, O ;
Munnich, A ;
Dreyfuss, G ;
Melki, J .
NATURE GENETICS, 1997, 16 (03) :265-269